17Capital related stories
All articles and analysis
Future 40 Leaders – 2026: DealmakersMeet the up-and-coming dealmakers featured in our Future 40 list for 2026.
Side Letter: Here be zombiesIn today's edition, Zombie funds could manage $1 trillion in NAV before the end of the decade; How managers can navigate private equity's 'new era'; Why there are limits to the speed at which secondaries can expand.
Meet the LP: KENFO, Germany's nuclear waste disposal fundThe €24bn investor has no future inflows and has an approach to private equity based almost entirely on outperformance, head of investment management Verena Kempe tells PEI.
Side Letter: Fund finance inflowsLP capital looks set to play a significant role in the rampant expansion of the fund finance universe. Plus: a $70bn pension is cutting its private equity allocation; and why LPs should investigate GPs' understanding of AI sustainability risks. Here's today's brief, for our valued subscribers only.
Side Letter: Carlyle's wealth boomCarlyle Group's efforts to raise more capital from wealthy individual investors appears to be going swimmingly. Plus: notes on 17Capital's latest fundraise; and another challenge on the horizon for Korean GPs. Here's today's brief, for our valued subscribers only.
Credit specialist Crescent taps ex-17Cap partner to lead GP financing strategyGregory Hardiman, who previously co-led 17Capital's US investment efforts, has been named managing director and head of GP-LP solutions at Crescent Capital.
LPs continue debate over continuation vehicles and NAV loans – updatedSpeaking at PEI's Women in Private Markets Summit, representatives from investors including NYCRS expressed caution about the rise of CVs on CVs, saying such practice could make GPs appear 'desperate'.
Side Letter: Money in or money out?New data suggests NAV loans are rarely used to massage DPI. Plus: a $23 billion pension has tweaked its PE allocation to get ahead of potential liquidity challenges; and a Japanese buyout firm completes an MBO. Here's today's brief, for our valued subscribers only.
Side Letter: Emerging manager optimismOne of the market's top placement firms reckons a new wave of emerging managers is about to hit the market. Plus: Why OTPP is a fan of continuation funds. Here's today's brief, for our valued subscribers only.
Arctos-backed Hayfin MBO represents 'trillion-dollar' opportunityThere are countless private markets firms that need a partner to help them grow in an era of scarce alpha and capital, says Arctos managing partner Ian Charles.